BARCELONA—AstraZeneca AZN-1.38%decrease; down pointing triangle said its new drug for chronic obstructive pulmonary disease showed benefits across a broad patient population in late-stage clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results